Skip to content

KMTS KMTS Stock-Based Comp

Stock-Based Comp at other companies

Abbott logo
AbbottABT
$317M+9.7%
Boston Scientific logo
Boston ScientificBSX
$83M+12.2%
Medtronic logo
MedtronicMDT
$95M+6.7%
iRhythm Holdings, Inc.
 logo
iRhythm Holdings, Inc. IRTC
$21.49M-7.9%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$8.96M-1.3%
Haemonetics logo
HaemoneticsHAE
$9.13M+31.6%

Other financials

Income statement

See full
Revenue$24.6M+62.7%
Gross profit$12.9M+97.1%
Operating income-$34.8M-68.8%
Net income-$34.2M-58.8%
EPS (diluted)-$0.61+51.2%

Balance sheet

See full
Cash & equivalents$291.3M+436%
Total debt$43.8M
Total assets$379.3M

Cash flow

See full
Operating cash flow-$18.4M-2.1%
CapEx$9.8M+141%
Free cash flow-$28.2M-27.7%

Valuation

See full
Market cap$1.29B+70.8%
Enterprise value$1.04B
P/S15.4×

Profitability

See full
Gross margin48.8%+15.1pp
Operating margin-171.5%+12.9pp
Net margin-173%+0.8pp
FCF margin-142.9%-25.3pp

Returns & leverage

See full
Current ratio7.3×

Where this comes from

Reported directly by KMTS in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: KMTS’s 10-Q, filed March 17, 2026, on SEC EDGAR. View the filing →

Ask your AI about KMTS's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is KMTS's stock-based comp?
KMTS (KMTS) reported stock-based comp of $10.11M in Q4 2025.
How has KMTS's stock-based comp changed year-over-year?
KMTS's stock-based comp increased by 2102.2% year-over-year, from $459K to $10.11M.
What does stock-based comp mean?
Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.